iris cardona breast cancer foundation

NYS Entity Status
ACTIVE

NYS Filing Date
AUGUST 25, 2014

NYS DOS ID#
4626373

County

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION RESERVATION

Name History
2014 - IRIS CARDONA BREAST CANCER FOUNDATION









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Fake Breast Cancer Charity Must Shut Down, Pay $350K To Real Charities
    By Laura Northrup - Friday Jun 16, 2017

    A purported charity called The Breast Cancer Survivors Foundation existed for six years, raising money through direct mailers and soliciting donors over the phone. It took in about $3 million per year, spinning heartwarming tales in its mailings of helping patients. This turned out to not actually be true, and those millions went to the professional fundraiser who ran the …

    Source: The Consumerist
  • Scientist's 'Tenacious' Research Paved Way for Breast-Cancer Treatment
    Friday Jun 16, 2017

    When Angela Hartley Brodie first came up with a new way to treat breast cancer in the 1970s, there was little interest from the pharmaceutical sector. But her persistence over the years paid off.

    Source: The Wall Street Journal: Technology: What's News
  • To Stave Off a Deportation, Cuomo Pardons a 9/11 Volunteer
    By SARAH MASLIN NIR - Wednesday Jun 21, 2017

    The governor expunged the crime of a 9/11 volunteer and undocumented immigrant facing removal by the immigration authorities because of a decades-old conviction.

    Source: NYT > Home Page
  • Women and Alcohol: One Glass a Day Linked to Cancer
    Tuesday May 30, 2017

    Even one small glass of wine or beer a day increases the risk of women developing breast cancer, according to a new report. Even the experts are surprised by the results. WSJ's Tanya Rivero reports. Photo: iStock

    Source: The Wall Street Journal: Most Popular This Week
  • Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs
    By Frank Vinluan - Wednesday Jun 14, 2017

    The IPO window is still open for clinical-stage drug companies, and Athenex is now the latest one to pass through it. The cancer drug developer raised $66 million through a public stock offering on Wednesday, funding that the company will devote mostly to a pair of cancer drugs in late-stage clinical development. Athenex priced its […]

    Source: Xconomy New York
  • “Operation Bottomfeeder”: A Shield for Legitimate Nonprofits
    By Ruth McCambridge - Monday Jun 19, 2017

    A recent case from New York illustrates why the nonprofit sector needs the attention of state regulators.

    Source: Nonprofit Quarterly
  • Water Iris Information – Learn About Water Iris Plant Care
    By Mary H. Dyer - Monday Jun 5, 2017

    By Mary H. Dyer, Master Naturalist and Master Gardener Ever heard of water iris? No, this doesn’t mean “watering” an iris plant but pertains to where the iris grows – in naturally wet or aquatic-like conditions. Read on for more water iris information. What is a Water Iris? Although several iris types grow in wet soil, true water iris is a semi-aquatic or bog plant that grows best in shallow water deep enough to cover the crown year round. However, most water iris plants will also grow in wet soil alongside a pond or stream, or even in a well-watered garden spot. True water irises include: Rabbit-ear iris Copper or red flag iris Siberian iris Louisiana iris Yellow flag iris Blue flag iris Water Iris Growing Conditions Planting a water iris in a wide pond plant basket or plastic pot to confine the growth is advisable, as some types of

    Source: Gardening Know How
  • Repare Nabs $68M To Find Synthetic Lethal Cancer Targets Beyond PARP
    By Corie Lok - Thursday Jun 22, 2017

    The concept of synthetic lethality has been around for decades, but only recently has it been exploited for cancer therapy. The idea is to hit cancer cells in at least two places at once; the trick is to find the right combination of genetic mutations that make the cells vulnerable. The newest company aiming to […]

    Source: Xconomy New York